These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Selective tolerance to discriminative stimulus effects of morphine or d-amphetamine.
    Author: Young AM, Walton MA, Carter TL.
    Journal: Behav Pharmacol; 1992 Jun; 3(3):201-209. PubMed ID: 11224117.
    Abstract:
    Pharmacological selectivity of tolerance to the discriminative stimulus effects of morphine or d amphetamine was examined in pigeons trained to discriminate among 3.2mg/kg morphine, saline, and 1.8mg/kg d-amphetamine under a 3-key fixed-ratio 30 schedule of food delivery. Cumulative doses of morphine (0.32-10mg/kg) or d-amphetamine (0.10-3.2mg/kg) evoked morphine-or d-amphetamine-key responding, respectively, in a dose-dependent manner. Suspending training and administering repeated doses of morphine (32mg/kg b.i.d.) for 1 week increased the dose of morphine required for morphine-key responding approximately 5-fold, without altering sensitivity to d-amphetamine. Conversely, repeated treatment with d-amphetamine (5.6mg/kg b.i.d.) increased the dose of d-amphetamine required for d-amphetamine-key responding approximately 7-fold, without decreasing sensitivity to morphine. Repeated treatment with saline (1ml/kg b.i.d.) for 1 or 2 weeks did not alter sensitivity to stimulus effects of either morphine or d-amphetamine. Sensitivity to stimulus effects of morphine recovered fully within 1 week after morphine treatment ended; sensitivity to stimulus effects of d-amphetamine recovered partially within 3 days after d-amphetamine treatment ended. For morphine, but not for d-amphetamine, increases in the dose required for stimulus effects were accompanied by increases in the dose required for rate-reducing effects. These results demonstrate that tolerance to discriminative stimulus effects of morphine and d-amphetamine is pharmacologically selective and suggest that pharmacotherapies targeted to one drug of abuse may produce little change in sensitivity to subjective effects of drugs from a different pharmacological class.
    [Abstract] [Full Text] [Related] [New Search]